迴天新材(300041.SZ):擬9000萬元增資廣州迴天 加大通信電子膠粘劑投入
格隆匯11月19日丨迴天新材(300041.SZ)公佈,為了增強對5G、通信電子用膠粘劑等新材料的戰略佈局,搶抓華為等客户所提供的合作發展機遇,促進公司產業結構升級,公司擬以自有資金向公司全資子公司廣州迴天進行增資,增資金額為9000萬元,並設立迴天通信電子材料技術研究院,主要用於5G和通信電子膠粘劑等新材料的研究開發與應用。
此次增資完成後,廣州迴天的註冊資本將由1000萬元增加至1億元,公司對廣州迴天的持股比例不變,廣州迴天仍為公司的全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.